PURIBLOOD MEDICAL CO., LTD.

PURIBLOOD

PuriBlood Medical was founded by Dr. Yung Chang in 2016.

PuriBlood developed a unique technology for blood cell separation that is supported by a world-class research center – R&D center for membrane technology (RDCMT).

PuriBlood, in conjunction with RDCMT, holds over 36+ patents supporting our core membrane technology. PuriBlood is committed to improving the blood filtration process with innovative technology of ‘Zwitterionic-bias Surface Coating Technology (ZISC technology)’.

Filtration Mechanism,

On the top layers of membrane structure, ZISC technol- ogy creates a membrane that is highly hydrated and compatible with human whole blood which is designed to evenly distribute the blood flow and trap the clots and microaggregates. (coarse-filtration)

In the core layers of membrane structure, ZISC technol- ogy provides a filter media with a specific affinity to selectively capture white blood cells and allows red blood cells to pass through the filter without rupture. (fine-filtration)

Our Company Vision:

Leadership

Leadership in product innovation.

Effectiveness

Extensive partnership /collaboration with clinicians to develop goods in demand.

Stability

Provide stable-quality cell filtration products to clients.

Flexibility

To satisfy clients’ requirements for various customized products of cell separation.